Xu, Linping

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4

Qin, S., Xu, L., Yi, M., Yu, S., Wu, K., & Luo, S. (2019) · Molecular Cancer

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 1,145

Regulation of PD-L1 expression in the tumor microenvironment

Yi, M., Niu, M., Xu, L., Luo, S., & Wu, K. (2021) · Journal of Hematology & Oncology

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 681

The role of cancer-derived microRNAs in cancer immune escape

Yi, M., Xu, L., Jiao, Y., Luo, S., Li, A., & Wu, K. (2020) · Journal of Hematology & Oncology

MicroRNA in disease regulationCancer Immunotherapy and Biomarkers

Cited by 221

The biology of combination immunotherapy in recurrent metastatic head and neck cancer

Yuan, X., Yi, M., Zhang, W., Xu, L., Chu, Q., Luo, S., & Wu, K. (2021) · The International Journal of Biochemistry & Cell Biology

Cancer Immunotherapy and BiomarkersHead and Neck Cancer Studies

Cited by 13